title: HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
abstract: Human immunodeficiency virus (HIV)-specific IgA can be detected in cervical secretions, saliva, and sera of HIV-infected and HIV-uninfected individuals with a known exposure to the virus. IgA from HIV-uninfected exposed seronegative individuals (ESN) neutralize in vitro primary strains of HIV-1. We analyzed the epitopes of HIV recognized by serum HIV-specific IgA of ESN individuals to identify the antigenic correlates of HIV neutralization in exposed-uninfected subjects, and to verify whether different epitopes would be recognized by HIV-specific IgA of ESN and of HIV-infected patients. Results confirmed that HIV-neutralizing IgA are detected in sera of ESN and showed that neutralization of primary HIV strains is mediated by the recognition of different epitopes in HIV-infected patients and ESN. Thus, whereas IgA of HIV+ individuals recognize epitopes expressed both within gp120 and gp41, IgA of ESN exclusively bind to gp41-expressed epitopes. Epitope mapping revealed that the epitope recognized by serum IgA of ESN on gp41 is restricted to aa 581-584 (LQAR) and corresponds to coiled coil pocket in the alpha helic region. In contrast, the epitope seen by IgA of HIV-infected patients on gp41 is identified by two regions; the first is contained within the cystein loop (aa 589-618), the second correspond to C terminal region in the extra membrane region of gp 41 (aa 642-673). Thus, we have identified and characterized the epitopes that mediate neutralization of HIV in individuals in whom infection does not occur despite multiple exposures to the virus. These results have important implications for the development of a new therapy against HIV infection.
authors.affiliation: DIBIT and Infectious Disease Clinic, San Raffaele Scientific Institute, Milano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Pastori
authors.forename: C
authors.initials: C
authors.lastname: Barassi
authors.forename: S
authors.initials: S
authors.lastname: Piconi
authors.forename: R
authors.initials: R
authors.lastname: Longhi
authors.forename: M L
authors.initials: ML
authors.lastname: Villa
authors.forename: A G
authors.initials: AG
authors.lastname: Siccardi
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: L
authors.initials: L
authors.lastname: Lopalco
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000595:Amino Acid Sequence; D018604:Epitope Mapping; D015483:HIV Antibodies / Q000276:immunology*; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D018023:HIV Seronegativity; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008969:Molecular Sequence Data; D014779:Virus Replication
chemical_list: D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D007070:Immunoglobulin A